Lung Cancer Research

December 3, 2015

Integrative-omics-derived genes to improve detection of lung cancer clinical subtypes

Mohammed Orloff, Ph.D.

More people die of lung cancer annually than of prostate, colon, and breast cancers combined, making it the leading cause of cancer-related mortality in the United States. There are two main categories of lung cancers: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC is the predominant lung cancer category accounting for…

Systems Biology Based Diagnosis of Circulating Lung Tumor Cells

Gunnar Boysen, Ph.D.

A UAMS research project is exploring how the special characteristics of growing lung cancer cells might be used to increase the effectiveness of individualized therapies to halt the disease. Gunnar Boysen, Ph.D., is lead investigator on the project,  “Systems Biology Based Diagnosis of Circulating Lung Tumor Cells,” and Rosalind Penney, Ph.D., is co-investigator. Boysen  …

November 23, 2015

FDA Contract Funds UAMS Lung Cancer Research

Nov. 23, 2015 | A UAMS physician-scientist has received a $764,000 contract from the Food and Drug Administration (FDA) to study a new method for lung cancer screening. Donald J. Johann Jr., M.D., will use the funding to determine if a simple blood test can detect lung cancer at an early stage, when the cancer…